WCLC 2025 - Posters & ePosters-EP.12.27 Effect of PD-L1 Expression Level on Clinical Outcomes of Stage IV EGFR Mutant Lung Cancer Patients Treated With Osimertinib

EP.12.27 Effect of PD-L1 Expression Level on Clinical Outcomes of Stage IV EGFR Mutant Lung Cancer Patients Treated With Osimertinib

Asset Subtitle

Jonathan Lee

Meta Tag

Speaker Jonathan Lee

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy